Definitive Contract 75N91024C00078
Award Date
9/16/24
Potential Completion Date
9/15/25
Potential Value
$454K
Federal Agency
National Cancer Institute
Awardee
Inbios International Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
17
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award for $389,535 was made to Electronic Biosciences, Inc., a small business biotechnology company, by the National Cancer Institute (NCI) under the Small Business Innovation Research (SBIR) program. The contract is for the development of an "IDEAL AT-HOME PROSTATE SPECIFIC ANTIGEN (PSA) TESTING" solution, which aligns with NCI's mission to support innovative technologies for cancer diagnostics and prevention. The contract is a Firm Fixed Price, Definitive...
The U.S. Department of Health and Human Services, specifically the Office of the Assistant Secretary for Preparedness and Response, awarded a $20,736,000 firm-fixed-price definitive contract to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the delivery of over-the-counter COVID-19 tests. The performance period is from September 20, 2023, to March 19, 2025. This contract has no set-aside designation, indicating...
This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...
This $299,584 firm fixed price contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Inbios International Inc. of Seattle, Washington to develop the Next-Gen Chagas DetectTM Plus rapid test for sensitive and specific diagnosis of Chagas disease. The contract is being performed under Phase I of the Small Business Innovation Research program in response to a solicitation seeking proposals for innovative solutions in infectious disease...
This is a $12,670,301.06 firm fixed-price definitive contract awarded by the U.S. Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Authority (BARDA) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the production capacity expansion of COVID-19 diagnostic tests and was awarded under Contracting Opportunity FA7013-20-S-0002, which did not have a set-aside designation....
This is a $25,655,995.03 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the development of COVID-19 antigen detection tests and optimization of serology assays as part of the FDA's Fast Track program. The contract has a period of performance through May 31, 2025. Inbios International Inc. has a history of providing critical testing products...
This federal contract award, valued at $4,708.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the procurement of "TEST KIT,VISCERAL L" and has a completion date of June 24, 2024. Inbios International Inc. is a veteran-owned, for-profit organization that specializes in the design, development, and manufacture of immunodiagnostic...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Triton Systems, Inc., a global product development and venturing company. The $399,925 firm-fixed-price contract is for the development of a low-cost, point-of-care detection device for prostate-specific antigen using a paper-based flow assay. This SBIR Phase I contract is part of the NCI's research efforts to...
This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...